跳至主要内容
临床试验/NCT01043965
NCT01043965已完成1 期

Evaluation of Myocardial Perfusion and Microvascular Reserve in Real-time Utilizing Myocardial Contrast Echocardiography in Type 2 Diabetes.

University of Sao Paulo General Hospital0 个研究点目标入组 61 人开始时间: 2005年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
61
主要终点
myocardial blood flow velocity, myocardial blood flow reserve

研究概览

简要总结

The investigators aimed to evaluate microvascular circulation with novel method: real-time myocardial contrast echocardiography in patients with type 2 diabetes and normal coronary arteries.

Myocardial blood flow reserve will be determined by quantitative contrast Stress echocardiography. Diabetic individuals will be evaluate in a decompensated state (Phase 1) and after optimization of medical treatment four months later (Phase 2).

详细描述

Early stages of epicardial atherosclerosis in patients with type 2 diabetes are associated with an impairment in endothelium-dependent dilation of the coronary microvasculature, indicating that the pathophysiological consequences of atherosclerosis may extend into the coronary microcirculation.

The investigators will evaluate three parameters of myocardial quantification with contrast Stress echocardiography and correlate with HbA1C levels.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Investigator)

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes mellitus
  • Normal echocardiogram
  • Absence of obstructive epicardial coronary disease

排除标准

  • Obstructive coronary disease
  • Heart valve disease
  • Cardiac Arrhythmias
  • Cardiomyopathy

研究组 & 干预措施

Diabetes

Active Comparator

Type 2 diabetes patients without obstructive coronary disease. Interventional group: lifestyle changes and treatment with metformin.

干预措施: Metformin (Drug)

结局指标

主要结局

myocardial blood flow velocity, myocardial blood flow reserve

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other

相似试验